PubMed Health⌕ Search

Biomedical subjects

L Tillman

Publications and source records attributed to L Tillman.

6 recordsLinked to original sources

Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers.

The gel forming characteristics of alginate in the presence of calcium ions and further crosslinking with poly-L-lysine led to the formation of sponge-like nano- and microparticles. The particle size was varied by adjusting the final concentrations of and proportions between the components. The region for particle formation was from 0.04 to 0.08% (w/v) of alginate in the final formulation, the change from the nm to microm size range occurred at a concentration of approx. 0.055% (w/v). Oligonucleotide-loaded microparticles were prepared by two different methods, either by absorption of the drug into the crosslinked polymeric matrix or by incorporation of an oligonucleotide/poly-L-lysine complex into a calcium alginate pre-gel. The release of oligonucleotide from microparticles prepared by the first method was higher. The addition of increasing amounts of poly-L-lysine resulted in larger particles, higher oligonucleotide loading and slower drug release. An increase in the final solid content of the formulation led to larger particles, especially with high concentrated calcium alginate pre-gels. Microparticles based on alginate and poly-L-lysine are potential carriers for antisense oligonucleotides.

Alginates↗

Characterization of complexes of an antisense oligonucleotide with protamine and poly-L-lysine salts.

The objectives of this work were to study the interaction of an antisense oligonucleotide (ISIS 2302) with poly-L-lysine (PLL) and protamine salts, to determine the physico-chemical characteristics of the resulting complex systems and to analyze the influence of permeation enhancers (Na-chenodeoxycholate and Na-caprate) on the dissociation of the complexes. Specific conductivity, zeta potential, particle size distribution and dialysis studies of the resulting complex systems were performed. Conductometric titration defined the molar ratios between the ionic species in the complex. Zeta potential data confirmed the conductometric equivalence points and explained the good physical stability of charged complexes when compared to neutral complexes (+/-40 mV for PLL-based complexes and +/-25 mV for protamine sulfate complexes). The particle size was less than 175 nm for most systems. The incorporation of Na-chenodeoxycholate promoted complex dissociation, while Na-caprate gave opposite results. An increase in the ionic strength of the environment had a destabilizing effect and promoted dissociation of the complexes.

Drug Delivery Systems↗

Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.

The objective of this study was to encapsulate an oligonucleotide drug within poly(lactide) microparticles with high encapsulation efficiencies at high theoretical drug loadings by the solvent evaporation method. With the conventional W/O/W method, the encapsulation efficiency decreased with increasing internal water content, increasing stirring time prior to filtration of the microparticles and increasing drug loading. The encapsulation was improved by replacing methylene chloride with ethyl acetate, by using micronized drug powder instead of an internal aqueous phase or by adding electrolytes or nonelectrolytes to the external phase. With ethyl acetate, a pre-emulsification step into a smaller volume of external aqueous phase was necessary in order to avoid premature polymer precipitation and to obtain microparticles. The addition of salts (NaCl or MgCl(2)) or sorbitol to the external aqueous phase significantly improved the encapsulation efficiency, even at high theoretical drug loadings. The microparticles had a denser structure with a smooth, pore-free surface.

Acetates↗

A comparison between propranolol and hypothermia in preventing ischemic contracture of the left ventricle (stone heart).

Ischemic contracture of the left ventricle ("stone heart") was studied utilizing a previously described stone heart model. Our studies suggest that beta-adrenergic blockade is not quantitatively as important as hypothermia in protecting ischemic myocardium. On the basis of reduced fibrillatory activity and a slight protective effect shown by electron microscopy, it would appear that combining propranolol with hypothermia may be superior to either used singly.

Animals↗